Avalo Therapeutics, Inc.

Pharmaceutical Preparations | SIC: 2834
Phone: 410-522-8707
CIK: 0001534120
EIN: 450705648
State Location: PA
State of Inc.: DE
Tickers:
  • Nasdaq:AVTX

Form: SCHEDULE 13G/A

Filing Date: 14 May 2026
Report Date:
Accepted: 14 May 2026 02:09 p.m.
Accession Number: 0001011438-26-000312
Act: 34
File Number: 005-89290
Film Number: 26978920

Documents

Primary Document
Accepted: 14 May 2026 02:09 p.m.